Kidney Transplant Immunosuppressive Therapy Adherence Trial (KITE)
Starting soon · Not applicable
Conditions studied: Kidney Transplantation, Medication Non-Adherence, Immunosuppressive Therapy, Renal Transplant Recipients
In brief
This randomized controlled interventional study aims to evaluate the effect of structured education and telephone counseling on immunosuppressive medication adherence among kidney transplant recipients. Poor adherence to immunosuppressive therapy after kidney transplantation is a major risk factor for acute rejection, graft loss, and increased morbidity. Education and behavioral support interventions delivered by nurses may improve medication understanding, adherence behaviors, and self-management skills. In this trial, 60 participants will be randomly assigned to either an intervention group receiving individualized education, an immunosuppressive medication adherence booklet, and scheduled telephone counseling sessions, or a control group receiving routine clinical care. Adherence will be assessed using the Immunosuppressive Medication Adherence Scale and biological monitoring through tacrolimus level variability over 8 weeks. Additional outcomes include changes in medication knowledge scores based on pre-test and post-test assessments. The study will contribute evidence regarding whether nurse-led telephone counseling and structured education can enhance adherence, improve clinical follow-up, and support long-term graft success in kidney transplant patients.
Key facts
- Study ID
- NCT07364123
- Run by
- University of Gaziantep
- People needed
- 60
- Starts
- 2026-01-05
- Expected to finish
- 2026-08-15
- Last updated by the study team
- 2026-01-28
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult kidney transplant recipients aged 18 years or older
- At least 1 month post-kidney transplantation
- Able to provide informed consent
- Cognitively intact and oriented to person, place, and time
- Able to communicate via telephone
- Voluntarily willing to participate in the study
You may not qualify if…
- Under 18 years of age
- Severe cognitive impairment preventing participation
- Inability to communicate effectively (hearing or speech limitations without support)
- Patients who do not meet the post-transplant time threshold (less than 1 month)
- Patients unwilling or unable to participate in follow-up sessions
Where it is running
- Gaziantep University Sahinbey Research and Application Hospital — Gaziantep, Şehitkamil, Turkey (Türkiye)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.